These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6320652)

  • 1. Morphologic and biochemical studies of canine mucopolysaccharidosis I.
    Shull RM; Helman RG; Spellacy E; Constantopoulos G; Munger RJ; Neufeld EF
    Am J Pathol; 1984 Mar; 114(3):487-95. PubMed ID: 6320652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII.
    Haskins ME; Otis EJ; Hayden JE; Jezyk PF; Stramm L
    Vet Pathol; 1992 Mar; 29(2):112-9. PubMed ID: 1632054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain.
    Dekaban AS; Constantopoulos G; Herman MM; Steusing JK
    Arch Pathol Lab Med; 1976 May; 100(5):237-45. PubMed ID: 817693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I.
    Kakkis E; McEntee M; Vogler C; Le S; Levy B; Belichenko P; Mobley W; Dickson P; Hanson S; Passage M
    Mol Genet Metab; 2004; 83(1-2):163-74. PubMed ID: 15464431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mucopolysaccharidosis V (Ullrich-Scheie syndrome) (author's transl)].
    Kovarik J; Vormittag W; Gebhart W; Ruthner U; Lubec G; Molzer B
    Wien Klin Wochenschr; 1978 Dec; 90(23):839-44. PubMed ID: 154210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy in feline mucopolysaccharidosis I.
    Kakkis ED; Schuchman E; He X; Wan Q; Kania S; Wiemelt S; Hasson CW; O'Malley T; Weil MA; Aguirre GA; Brown DE; Haskins ME
    Mol Genet Metab; 2001 Mar; 72(3):199-208. PubMed ID: 11243725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic changes of the ear in canine models of mucopolysaccharidosis types I and VII.
    Hordeaux J; Deniaud J; Bemelmans I; Bertrand L; Moreau S; Amiaud J; Wyers M; Cherel Y; Colle MA
    Vet Pathol; 2011 May; 48(3):616-26. PubMed ID: 20930106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycan storage in neuroanatomical regions of mucopolysaccharidosis I dogs following intrathecal recombinant human iduronidase.
    Chen A; Vogler C; McEntee M; Hanson S; Ellinwood NM; Jens J; Snella E; Passage M; Le S; Guerra C; Dickson P
    APMIS; 2011 Aug; 119(8):513-21. PubMed ID: 21749451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncirrhotic portal hypertension and nodular regenerative hyperplasia of the liver in dogs with mucopolysaccharidosis type I.
    McEntee MF; Wright KN; Wanless I; DeVovo R; Schneider JF; Shull R
    Hepatology; 1998 Aug; 28(2):385-90. PubMed ID: 9696001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corneal opacity in canine MPS I. Changes after bone marrow transplantation.
    Constantopoulos G; Scott JA; Shull RM
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1802-7. PubMed ID: 2503461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
    Fuller M; Meikle PJ; Hopwood JJ
    Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.
    Shull RM; Hastings NE; Selcer RR; Jones JB; Smith JR; Cullen WC; Constantopoulos G
    J Clin Invest; 1987 Feb; 79(2):435-43. PubMed ID: 3100576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
    Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP
    Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfamidase deficiency in a family of Dachshunds: a canine model of mucopolysaccharidosis IIIA (Sanfilippo A).
    Fischer A; Carmichael KP; Munnell JF; Jhabvala P; Thompson JN; Matalon R; Jezyk PF; Wang P; Giger U
    Pediatr Res; 1998 Jul; 44(1):74-82. PubMed ID: 9667374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I.
    Kakkis ED; McEntee MF; Schmidtchen A; Neufeld EF; Ward DA; Gompf RE; Kania S; Bedolla C; Chien SL; Shull RM
    Biochem Mol Med; 1996 Aug; 58(2):156-67. PubMed ID: 8812735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs.
    Chiaro JA; O'Donnell P; Shore EM; Malhotra NR; Ponder KP; Haskins ME; Smith LJ
    J Bone Miner Res; 2014 Dec; 29(12):2610-7. PubMed ID: 24898323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine alpha-L-iduronidase deficiency. A model of mucopolysaccharidosis I.
    Shull RM; Munger RJ; Spellacy E; Hall CW; Constantopoulos G; Neufeld EF
    Am J Pathol; 1982 Nov; 109(2):244-8. PubMed ID: 6215865
    [No Abstract]   [Full Text] [Related]  

  • 18. Craniofacial abnormalities in animal models of mucopolysaccharidoses I, VI, and VII.
    Sheridan O; Wortman J; Harvey C; Hayden J; Haskins M
    J Craniofac Genet Dev Biol; 1994; 14(1):7-15. PubMed ID: 8006122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I.
    Dickson P; Peinovich M; McEntee M; Lester T; Le S; Krieger A; Manuel H; Jabagat C; Passage M; Kakkis ED
    J Clin Invest; 2008 Aug; 118(8):2868-76. PubMed ID: 18654665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector.
    Kobayashi H; Carbonaro D; Pepper K; Petersen D; Ge S; Jackson H; Shimada H; Moats R; Kohn DB
    Mol Ther; 2005 May; 11(5):776-89. PubMed ID: 15851016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.